Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Germany with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Not applicable Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20121
20161
20211
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany2
Angiodynamics, Inc.1
Boston Scientific Corporation1
HistoSonics, Inc.1
Lindis Bloodcare GmbH1
Maastricht University1
Pfizer1
Terumo Europe N.V.1
University Hospital Heidelberg1
University of Leipzig1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular11
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Cholangiocarcinoma2
Gallbladder Neoplasms2
Adenoma, Islet Cell1
Breast Neoplasms1
Colonic Neoplasms1
Endometrial Neoplasms1
Gastrointestinal Stromal Tumors1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.